The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
another fundraising mentioned in the results happens today apparently. The only concern I have for this share is if GPs decide to work from home after Covid as many are at the moment.
Cross contamination of ideas? Have a look at H2Bus consortium which includes Wright Bus Ryse Hydrogen Ballard Everfuel and Nel who are supporting the large scale adoption of H2 in public transport Sadly ITM apparently are not involved despite their connections. and Nel are the supplier of electolizers across Europe which some success as my post earlier this week
https://news.cision.com/nel-asa/r/nel-asa--enters-into-framework-agreement-for-delivery-of-electrolysers-in-france,c3093166
Nel is still doing business in Europe despite the problems we all face
I agree as expected albeit somewhat surprised how low revenue was compared to the 2018 contracted value and the hit they have recognised for project delays. Fuel sales on the other hand representing 10% of revenue is an interesting number . I will wait patiently for a point to buy in again as I am sure ITM have a great future ahead of it.
interesting if you look at other H2 related shares several have the same chart profile with a substantial rise in late Dec early Jan followed by a marked decline around this time. Monday will be a turning point one way or another just as Ceres was today